Feedback / Questions
MOD-9017 - OPKO Health
Investor Conference Call
(Prolor-Biotech)
-
Sep 7, 2011 -
Factor IX-CTP / Prolor Biotech; Anticipated P2 study regulatory clearance in Q2 & Q3 '12
Anticipated P2 regulatory clearance
•
Hemophilia
http://www.larvolonline.com/tlg/ccdb/ProlorBiotechInvestorConferenceCallSep7th'11.pdf
Sep 7, 2011
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious